Robert Bruce acquired 150k Supernus Pharmaceuticals shares worth $6.3M. That's 2.12% of their equity portfolio (18th largest holding). The first Supernus Pharmaceuticals trade was made in Q2 2014. Since then Robert Bruce bought shares seven more times and sold shares on thirteen occasions. The stake costed the investor $2.8M, netting the investor a gain of 125% so far.